Showing results (1761-1770 of 2,107) with videos related to
Sort By:
Pageof 211
CNS Drugs|October 31, 2018
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy SubjectsLesley Taylor, Barry Gidal, Graham Blakey, et al.CNS Drugs|November 25, 2016
Alemtuzumab Use in Clinical Practice: Recommendations from European Multiple Sclerosis ExpertsThomas Berger, Irina Elovaara, Sten Fredrikson, et al.CNS Drugs|December 13, 2016
New Non-Intravenous Routes for Benzodiazepines in Epilepsy: A Clinician PerspectiveMarco MulaCNS Drugs|December 13, 2016
Targeting Functional Impairments in the Treatment of Children and Adolescents with ADHDTyler Sasser, Erin N Schoenfelder, Mark A SteinCNS Drugs|November 30, 2016
Anesthetics and Outcome in Status Epilepticus: A Matched Two-Center Cohort StudyRaoul Sutter, Gian Marco De Marchis, Saskia Semmlack, et al.CNS Drugs|December 4, 2016
Serotonin 5-HT6 Receptor Antagonists in Alzheimer's Disease: Therapeutic Rationale and Current Development StatusHilda Ferrero, Maite Solas, Paul T Francis, et al.CNS Drugs|February 19, 2008
Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: epidemiology, prevention and managementJohnny Graham, David CoghillCNS Drugs|February 19, 2008
Spotlight on risperidone in irritability associated with autistic disorder in children and adolescentsLesley J Scott, Sohita DhillonCNS Drugs|January 13, 2017
Benzodiazepine Use and Risk of Developing Alzheimer's Disease: A Case-Control Study Based on Swiss Claims DataFabienne A Biétry, Alena M Pfeil, Oliver Reich, et al.CNS Drugs|March 17, 2019
Skin-Picking Disorder: A Guide to Diagnosis and ManagementMohammad Jafferany, Arsh PatelPageof 211